qEEG and Alzheimer's disease.

نویسندگان

  • Ángel Golimstok
  • Juan Ignacio Rojas
  • Edgardo Cristiano
چکیده

We read with great interest the article published by Fonseca et al. about the contribution of quantitative electroencephalographic (qEEG) analyses in the diagnosis of Alzheimer’s disease (AD)1. In this article, the authors concluded that the study of coherence and power in the qEEG showed a relatively limited accuracy, with respect to its application in the routine clinical practice. Beyond this great paper, some concerns arouse regarding methodological issues of the research. First of all, the authors state that one exclusion criterion was “a score lower than 4 on the Hachinski scale in order to minimize the possibility of vascular disease and focal lesions in the neuroimaging exams”. We believe that it is a type error because if “Hachinski scale lower than 4” was an exclusion criterion, all patients included were higher than four, so patients with vascular dementia were included2. Second, it is very difficult to explain a Control Group with significant lower education compared to AD patients, mainly because this variable might affect on MMSE and, precisely, this instrument was used to differentiate cases from control patients3. Finally, another issue to point and to analyze when results are discussed is the fact that depression was not consider in exclusion/inclusion criteria, considering that such condition could affect on EEG in patients with dementia as previously reported4. Despite these issues, we consider that the paper is very interesting, as well as a novel research that wakes up a renew interest of qEEG in the diagnosis of AD patients. Our congratulations to the authors.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease.

BACKGROUND Successful early detection of mild cognitive impairment (MCI) and Alzheimer's disease demands the identification of biomarkers capable of distinguishing individuals with prodromal or early cognitive impairment from healthy aging adults. Many laboratories are engaged in the discovery and validation of a wide array of potential genetic, proteomic, cognitive, and other types of biomarke...

متن کامل

Quantitative electroencephalography power and coherence measurements in the diagnosis of mild and moderate Alzheimer's disease.

OBJECTIVE To evaluate the contribution of quantitative electroencephalographic (qEEG) analyses in the diagnosis of Alzheimer's disease (AD). METHOD Thirty-five patients from the Neurology Outpatients Clinic of PUC-Campinas, diagnosed with AD according to the NINCDS/ADRDA were evaluated, and compared with a control group consisting of 30 individuals with no cognitive deficit. The procedures co...

متن کامل

qEEG spectral peak in Alzheimer’s disease: A possible tool for treatment follow-up

qEEG spectral analysis has been considered highly sensitive to cortical functional changes and agrees strongly with the clinical diagnosis of AD. The sensitivity of spectral analysis has ranged from 71% to 81% in several studies.1-3. Objective The aim of this study was to retrospectively evaluate whether alpha qEEG spectral peak can supplement clinical examination by constituting an independe...

متن کامل

Quantitative EEG markers relate to Alzheimer's disease severity in the Prospective Dementia Registry Austria (PRODEM).

OBJECTIVE To investigate which single quantitative electro-encephalographic (QEEG) marker or which combination of markers correlates best with Alzheimer's disease (AD) severity as measured by the Mini-Mental State Examination (MMSE). METHODS We compared quantitative EEG markers for slowing (relative band powers), synchrony (coherence, canonical correlation, Granger causality) and complexity (...

متن کامل

Random forest to differentiate dementia with Lewy bodies from Alzheimer's disease

INTRODUCTION The aim of this study was to build a random forest classifier to improve the diagnostic accuracy in differentiating dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) and to quantify the relevance of multimodal diagnostic measures, with a focus on electroencephalography (EEG). METHODS A total of 66 DLB, 66 AD patients, and 66 controls were selected from the Amsterdam D...

متن کامل

Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.

Cholinesterase inhibitors improve cognition and behaviour in some patients with Alzheimer's disease (AD). Studies that have focused on methods to predict response to anticholinesterase therapy and markers for response are reviewed. Among the possible predictors of improvement in cognitive outcomes are apolipoprotein genotype, pretreatment postural blood pressure drop, quantitative electroenceph...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Arquivos de neuro-psiquiatria

دوره 70 6  شماره 

صفحات  -

تاریخ انتشار 2012